NCT07602842 A Study of IDP-001 in Advanced or Metastatic Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07426484 Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy Status NOT_YET_RECRUITING Phase PHASE4
NCT06644079 Window of Opportunity Study of Topical Tranexamic Acid for Cutaneous Squamous Cell Carcinoma Status WITHDRAWN Phase PHASE2
NCT06577311 Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis) Status RECRUITING Phase PHASE2
NCT06567314 Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06536946 B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers Status RECRUITING Phase N/A
NCT06384820 Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC) Status WITHDRAWN Phase PHASE2
NCT06288191 Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06171750 Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06046625 Needs and Preferences of Patients With Head-neck Cutaneous SCC Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06036836 Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010) Status COMPLETED Phase PHASE2